| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $2,989,506 | 5 | 100 |
Sells | $0 | 0 | 0 |
| FROST PHILLIP MD ET AL | CEO & Chairman | 4 | $2.98M | 0 | $0 | $2.98M |
| PAGANELLI JOHN A | director | 1 | $11,350 | 0 | $0 | $11,350 |
OPKO Health, Inc. operates as a healthcare enterprise with a dual focus on diagnostics and pharmaceuticals. Its operations span the United States, Ireland, Chile, Spain, Israel, Mexico, and other international markets. The company's Diagnostics division encompasses BioReference Laboratories, which delivers a comprehensive suite of laboratory testing services. These services are crucial for disease detection, diagnosis, evaluation, monitoring, and treatment, covering areas such as esoteric testing, molecular diagnostics, anatomical pathology, …
Over the last 12 months, insiders at OPKO Health, Inc. have bought $2.99M and sold $0 worth of OPKO Health, Inc. stock.
On average, over the past 5 years, insiders at OPKO Health, Inc. have bought $6.85M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: FROST PHILLIP MD ET AL (CEO & Chairman) — $2.98M. PAGANELLI JOHN A (director) — $11,350.
The last purchase of 10,000 shares for transaction amount of $11,350 was made by PAGANELLI JOHN A (director) on 2026‑03‑20.
| 2026-03-20 | PAGANELLI JOHN A | director | 10,000 0.0013% | $1.14 | $11,350 | +24.11% | ||
| 2025-11-21 | FROST PHILLIP MD ET AL | CEO & Chairman | 580,000 0.0759% | $1.33 | $768,807 | 0.00% | ||
| 2025-11-20 | FROST PHILLIP MD ET AL | CEO & Chairman | 580,000 0.0773% | $1.33 | $771,328 | +1.54% | ||
| 2025-11-19 | FROST PHILLIP MD ET AL | CEO & Chairman | 580,000 0.0755% | $1.31 | $759,115 | +0.76% | ||
| 2025-11-18 | FROST PHILLIP MD ET AL | CEO & Chairman | 533,300 0.0691% | $1.27 | $678,906 | +3.13% | ||
| 2025-10-31 | FROST PHILLIP MD ET AL | CEO & Chairman | 150,000 0.0201% | $1.42 | $213,435 | -2.94% | ||
| 2025-08-08 | FROST PHILLIP MD ET AL | CEO & Chairman | 675,000 0.0898% | $1.32 | $891,000 | +5.60% | ||
| 2025-04-10 | FROST PHILLIP MD ET AL | CEO & Chairman | 125,000 0.0165% | $1.36 | $169,713 | -1.84% | ||
| 2025-04-08 | FROST PHILLIP MD ET AL | CEO & Chairman | 125,000 0.018% | $1.48 | $184,650 | -8.22% | ||
| 2025-04-01 | FROST PHILLIP MD ET AL | CEO & Chairman | 100,000 0.0148% | $1.65 | $164,850 | -19.28% | ||
| 2025-03-28 | FROST PHILLIP MD ET AL | CEO & Chairman | 150,000 0.0223% | $1.70 | $254,385 | -21.18% | ||
| 2025-03-17 | FROST PHILLIP MD ET AL | CEO & Chairman | 200,000 0.0286% | $1.74 | $347,820 | -25.41% | ||
| 2025-02-28 | FROST PHILLIP MD ET AL | CEO & Chairman | 67,434 0.0097% | $1.71 | $115,312 | -21.84% | ||
| 2025-01-28 | FROST PHILLIP MD ET AL | CEO & Chairman | 47,537 0.0069% | $1.47 | $70,060 | -8.00% | ||
| 2025-01-17 | FROST PHILLIP MD ET AL | CEO & Chairman | 150,000 0.022% | $1.47 | $220,425 | -6.12% | ||
| 2025-01-15 | FROST PHILLIP MD ET AL | CEO & Chairman | 500,000 0.0731% | $1.48 | $740,850 | -6.12% | ||
| 2024-12-13 | FROST PHILLIP MD ET AL | CEO & Chairman | 125,000 0.0182% | $1.59 | $199,375 | -11.32% | ||
| 2024-12-11 | FROST PHILLIP MD ET AL | CEO & Chairman | 500,000 0.0713% | $1.56 | $781,050 | -11.32% | ||
| 2024-11-29 | FROST PHILLIP MD ET AL | CEO & Chairman | 199,072 0.0291% | $1.53 | $305,376 | -7.14% | ||
| 2024-11-22 | FROST PHILLIP MD ET AL | CEO & Chairman | 100,000 0.0147% | $1.59 | $159,000 | -9.49% |
| FROST PHILLIP MD ET AL | CEO & Chairman | 216706448 29.0363% | $372.74M | 1164 | 0 | +10.41% |
| PAGANELLI JOHN A | director | 394340 0.0528% | $678,264.80 | 7 | 0 | +0.7% |
| Frost Gamma Investments Trust | director | 198131694 26.5475% | $340.79M | 21 | 0 | <0.0001% |
| HSIAO JANE PH D | Vice Chairman & CTO | 27999880 3.7517% | $48.16M | 27 | 0 | +10.55% |
| Zerhouni Elias A. | Vice Chairman and President | 20327814 2.7237% | $34.96M | 2 | 0 | +12.95% |
| Rubin Steven D | Executive VP-Administration | 6187732 0.8291% | $10.64M | 15 | 2 | +0.53% |
| Fishel Robert Scott | director | 4120728 0.5521% | $7.09M | 10 | 0 | +1.68% |
| Nabel Gary J. | Chief Innovation Officer | 351442 0.0471% | $604,480.24 | 4 | 0 | <0.0001% |
| PFENNIGER RICHARD C JR | director | 325000 0.0435% | $559,000.00 | 5 | 0 | +19.46% |
| BARON ROBERT A | director | 284088 0.0381% | $488,631.36 | 3 | 2 | <0.0001% |
| Logal Adam | Sr. Vice President, CFO | 179162 0.024% | $308,158.64 | 4 | 3 | <0.0001% |
| LERNER RICHARD A | director | 166172 0.0223% | $285,815.84 | 6 | 0 | <0.0001% |
| Cohen Jon R | SVP OPKO; Exec Chairman BRLI | 125000 0.0167% | $215,000.00 | 1 | 0 | +4.52% |
| KRASNO RICHARD M | director | 103333 0.0138% | $177,732.76 | 1 | 0 | +40.2% |
| Japour Anthony J | director | 1000 0.0001% | $1,720.00 | 2 | 0 | +171.36% |
| Increased Positions | 77 | +25.58% | 16M | +8.01% |
| Decreased Positions | 115 | -38.21% | 12M | -6.29% |
| New Positions | 31 | New | 4M | New |
| Sold Out Positions | 36 | Sold Out | 2M | Sold Out |
| Total Postitions | 263 | -12.62% | 200M | +1.72% |
| Rubric Capital Management Lp | $60,695.00 | 6.22% | 47.79M | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $47,671.00 | 4.89% | 37.54M | -702,817 | -1.84% | 2025-09-30 |
| Blackrock, Inc. | $42,129.00 | 4.32% | 33.17M | +2M | +5.48% | 2025-09-30 |
| Geode Capital Management, Llc | $13,962.00 | 1.43% | 10.99M | +568,872 | +5.46% | 2025-09-30 |
| State Street Corp | $11,427.00 | 1.17% | 9M | +416,100 | +4.85% | 2025-09-30 |
| Whitefort Capital Management, Lp | $6,223.00 | 0.64% | 4.9M | +3M | +176.18% | 2025-09-30 |
| Ubs Group Ag | $6,065.00 | 0.62% | 4.78M | -944,096 | -16.51% | 2025-09-30 |
| Charles Schwab Investment Management Inc | $4,787.00 | 0.49% | 3.77M | +418,558 | +12.49% | 2025-09-30 |
| Northern Trust Corp | $4,645.00 | 0.48% | 3.66M | +175,574 | +5.04% | 2025-09-30 |
| Aqr Capital Management Llc | $3,649.00 | 0.37% | 2.87M | +2M | +207.02% | 2025-09-30 |